It stacks it on top of every other stressor in your life work pressure, family obligations, financial stress, poor sleep, and the baseline hormonal shifts that come with being over 40
Semaglutide and Tirzepatide Semaglutide is primarily a GLP-1 receptor agonist Tirzepatide targets GLP-1 and GIP receptors Retatrutide targets GLP-1, GIP, and glucagon receptor pathways Because retatrutide activates additional metabolic receptors, some studies suggest that retatrutide may deliver greater weight loss compared with semaglutide and tirzepatide
100% achieved 5% Weight loss was dose-dependent: 4mg (-17.1%), 8mg (-22.8%), 12mg (-24.2%) at 48 weeks Results appeared early (visible by week 4) and continued throughout the 48-week trial Beyond weight: significant improvements in blood pressure, lipids, liver fat, and glycemic control Investigational Drug: Retatrutide is not FDA-approved
the ceiling, by design, will not move down
Moiz noted that oral semaglutide and orforglipron (Eli Lilly), which were also as effective as currently available agents
